Keeping your Liver Healthy when you have Hepatitis C

 

Here are some things to remember about keeping your liver healthy if you have hepatitis C:

  • Don't drink alcohol. Alcohol can cause further swelling and irritation of your liver, and drinking increases your chances of cirrhosis. No one knows if there is a safe amount of alcohol for patients with liver disease.
  • Get tested for hepatitis A. A blood test can tell if you are already immune to hepatitis A. If you have hepatitis C, and you are not immune to hepatitis A, you should get vaccinated for it. If you have hepatitis C, you have a higher chance of getting very sick if you get hepatitis A.
  • Get tested for hepatitis B. The test can tell if you have ever been exposed to hepatitis B. If you haven't been exposed, you should get vaccinated if:
    • you belong to a group at risk for hepatitis B (such as health care workers)
    • you have been involved in high-risk sexual behavior
    • there is any chance of your using or sharing needles for illegal drug use
    If you are already immune to hepatitis B, you should be protected from getting it again.
  • Be careful with medications. Occasional use of low-dose acetaminophen (commonly known as Tylenol) is OK. A general rule is to take half the dose recommended on the bottle. It is also OK to take ibuprofen (Motrin or Advil) if you do not have cirrhosis. Regular aspirin is fine if it doesn't bother your stomach.
  • Be careful about vitamins and minerals. Avoid iron supplements unless prescribed by your doctor (as long as your doctor knows you have hepatitis C). Iron might speed up the process of liver scarring, particularly when taken in large doses.
  • Be careful about herbal remedies. Some patients ask to take the herb "milk thistle," believing it can reduce swelling in the liver. Whether milk thistle works or not is unknown. However, be cautious when taking any herb. U.S. regulations do not require that these products be tested for quality.
Latest Hepatitis News
Impressive Vertex hepatitis C drug data unveiled

November 1, 2008 - A closely watched hepatitis C treatment being developed by Vertex Pharmaceuticals Inc showed an impressive ability to knock out the virus in patients who failed other treatments and those not previously treated for the serious liver disease, data from mid-stage studies show.

U.S. hepatitis A vaccine rates vary widely

January 25, 2012 — NEW YORK (Reuters Health) - Although about 85 percent of kids in two U.S. states have had a complete set of hepatitis A vaccines, overall just three in 10 have had both shots, according to a new survey from the Centers for Disease Control and Prevention (CDC).

Device makers urge coverage of weight-loss surgery

January 25, 2012 — CHICAGO (Reuters) - Device manufacturers are pushing the U.S. government and health insurers to cover weight-loss surgery, an effort that could give millions more obese Americans access to the treatments.

Arsenic cancer risk still high decades later

January 24, 2012 — NEW YORK (Reuters Health) - People exposed to very high levels of arsenic in Chilean drinking water back in the 1950s and 60s are still showing a higher-than-normal risk of bladder cancer -- years after the arsenic problem was brought under control, a new study shows.

Select news items provided by Reuters Health